These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 12229257)

  • 21. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
    Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K; Androne AS; Hudaihed A; Katz SD
    Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using carvedilol to treat heart failure.
    Taccetta-Chapnick M
    Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
    [No Abstract]   [Full Text] [Related]  

  • 24. Carvedilol [Coreg].
    Kukin M
    Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacogenetics and heart failure: a convergence with carvedilol.
    Meadowcroft AM; Williamson KM; Patterson JH; Pieper JA
    Pharmacotherapy; 1997; 17(4):637-9. PubMed ID: 9250542
    [No Abstract]   [Full Text] [Related]  

  • 26. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
    Torp-Pedersen CT;
    Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
    [No Abstract]   [Full Text] [Related]  

  • 27. Controlled-release carvedilol: a concluding perspective.
    Packer M
    Am J Cardiol; 2006 Oct; 98(7A):67L-69L. PubMed ID: 17023235
    [No Abstract]   [Full Text] [Related]  

  • 28. Carvedilol following AMI.
    Herner SJ; Seaton TL
    J Fam Pract; 1997 Oct; 45(4):288-9. PubMed ID: 9379146
    [No Abstract]   [Full Text] [Related]  

  • 29. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

  • 30. Does carvedilol have antiarrhythmic properties?
    Naccarelli GV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):338-9. PubMed ID: 16265556
    [No Abstract]   [Full Text] [Related]  

  • 31. beta-Blockers in hypertension: is carvedilol different?
    Messerli FH; Grossman E
    Am J Cardiol; 2004 May; 93(9A):7B-12B. PubMed ID: 15144930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carvedilol and adrenergic agonists suppress the lipopolysaccharide-induced NO production in RAW 264.7 macrophages via the adrenergic receptors.
    Pekarova M; Kralova J; Kubala L; Ciz M; Papezikova I; Macickova T; Pecivova J; Nosal R; Lojek A
    J Physiol Pharmacol; 2009 Mar; 60(1):143-50. PubMed ID: 19439816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MUCHA(Multicenter Carvedilol Heart Failure Dose Assessment Trial)].
    Aoyama N
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():526-30. PubMed ID: 17508586
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of carvedilol on seizure induction during electroconvulsive therapy procedure.
    Syed N
    J ECT; 2009 Mar; 25(1):60. PubMed ID: 18978602
    [No Abstract]   [Full Text] [Related]  

  • 35. Carvedilol overdose with quantitative confirmation.
    Bouchard NC; Forde J; Hoffman RS
    Basic Clin Pharmacol Toxicol; 2008 Jul; 103(1):102-3. PubMed ID: 18598302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
    Bosimini E
    Ital Heart J Suppl; 2001 Aug; 2(8):919-21. PubMed ID: 11582729
    [No Abstract]   [Full Text] [Related]  

  • 37. Carvedilol for heart failure: more than just a beta-blocker?
    Cleland JG
    Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):493-7. PubMed ID: 10193451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale and design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) study.
    Gheorghiade M; Gattis WA; Lukas MA; O'Connor CM;
    Am Heart J; 2003 Feb; 145(2 Suppl):S60-1. PubMed ID: 12594455
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple action compounds in angina pectoris.
    Kelly DT; Freedman SB
    Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Did Carvedilol Really Have More Severe Adverse Events than Propranolol in Cirrhotic Patients?
    Lo GH
    Am J Gastroenterol; 2017 May; 112(5):808. PubMed ID: 28469221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.